More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$28.20B
EPS
10.04
P/E ratio
24.5
Price to sales
2.21
Dividend yield
1.342%
Beta
0.546802
Previous close
$262.21
Today's open
$260.65
Day's range
$256.09 - $262.94
52 week range
$171.18 - $263.19
show more
CEO
James E. Davis
Employees
57000
Headquarters
Secaucus, NJ
Exchange
New York Stock Exchange
Shares outstanding
110019073
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
Quest Diagnostics Incorporated (DGX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Quest Diagnostics Incorporated (DGX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha • Nov 17, 2026

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 12, 2026

Quest Diagnostics Declares Quarterly Cash Dividend
SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record of Quest Diagnostics common stock on January 12, 2027.
PRNewsWire • Nov 10, 2026

Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference
SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference in Miami on Tuesday, December 1, 2026, at 2:10 p.m.
PRNewsWire • Nov 9, 2026

Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London
SECAUCUS, N.J., Nov. 9, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, 2026, at 8:30 a.m.
PRNewsWire • Nov 9, 2026

The big winners of the tech wreck are biopharma stocks
Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? Companies like Johnson & Johnson, Quest Diagnostics and UnitedHealth Group have long been known for producing steady results, driven by patient demand and government reimbursement.
Market Watch • Oct 30, 2026

Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Oct 27, 2026

Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
The Sustainable Value Strategy trailed its benchmark, the Russell 2500 Value Index, in the third quarter. New positions include Lineage, Birkenstock, Matador Resources, KBR and ICON. InterDigital, Stevanato Group and Exelixis rounded out our top contributors.
Seeking Alpha • Oct 27, 2026

Quest Diagnostics Upgraded After Strong Q3, While Also Announcing New Test For Alzheimer's
Quest Diagnostics is upgraded to a strong buy, driven by robust earnings momentum, sector resilience, and sustained outperformance versus benchmarks. DGX delivered its fourth consecutive earnings beat, with Q3 revenue up 10% YoY and EPS up 28.7%, prompting raised full-year guidance. Quest's competitive edge is reinforced by superior margins, a strong ROE above 15%, ongoing innovation, and an investment-grade balance sheet with declining leverage.
Seeking Alpha • Oct 27, 2026

Lab testing giant Quest Diagnostics confirms patients' personal and health data was compromised during breach
Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information stored in its systems, according to a legally required disclosure with U.S. regulators.
TechCrunch • Oct 23, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Quest Diagnostics Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.